Last Updated: October 1, 2026

Details for Patent: 7,351,834

Name: Drug Patent Intelligence for US Patent 7351834
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,351,834

Title:	ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
Abstract:	This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Inventor(s):	Bernd Riedl, Jacques Dumas, Uday Khire, Timothy Lowinger, William Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert Sibley
Assignee:	Bayer Healthcare LLC
Application Number:	US09/889,227
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,351,834
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,351,834

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,351,834

PCT Information
PCT Filed	January 12, 2000	PCT Application Number:	PCT/US00/00648
PCT Publication Date:	July 20, 2000	PCT Publication Number:	WO00/42012

International Family Members for US Patent 7,351,834

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1140840	⤷ Start Trial	91280	Luxembourg	⤷ Start Trial
European Patent Office	1140840	⤷ Start Trial	PA2006008	Lithuania	⤷ Start Trial
European Patent Office	1140840	⤷ Start Trial	300242	Netherlands	⤷ Start Trial
European Patent Office	1140840	⤷ Start Trial	06C0034	France	⤷ Start Trial
European Patent Office	1140840	⤷ Start Trial	CA 2007 00002	Denmark	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.